blindness

Cancer drug shows promise as treatment for blindness

/ Cancer, Research update / / ,

by Agency for Science, Technology and Research (A*STAR), Singapore edited by Sadie Harley, reviewed by Andrew Zinin PRL3 (but not PRL1) is associated with embryonic angiogenesis and blood vessels in PRL3+ tumors have reduced pericyte coverage compared to those in PRL3- tumors. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59929-2 Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute […]

Cancer drug shows promise as treatment for blindness Read More »

Can You Eat Away the Risk for Blindness? –

/ Clinical Practice / /

Many clinicians wonder if their advice about smoking cessation, diet, and exercise has much effect on patients. But people with family histories of age-related macular degeneration (AMD) may be more receptive than others. Given the dearth of effective treatments once patients have reached the late stage of the disease, they may be motivated by hearing

Can You Eat Away the Risk for Blindness? – Read More »

Unlocking the genetics of blindness: New hope for sufferers of inherited retinal diseases

/ Research update / /

by Greg Bruno, University of Oklahoma edited by Stephanie Baum, reviewed by Andrew Zinin   A patient with autosomal recessive RP had novel homozygous variant in GNAT1. (A,B) GP2-27 images revealed preservation of the fovea, including the outer nuclear layer and ellipsoid zone, with adjacent outer retinal degeneration. (C,D) Patient’s left eye has vascular attenuation, faint RPE changes

Unlocking the genetics of blindness: New hope for sufferers of inherited retinal diseases Read More »

Need Help?

We are here to help.

Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.

Contact Us Now
InnovateMed Medical Group

✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866

Review Rating
Instagram Facebook Linkedin X-twitter
Scroll to Top